ROSACEA PATIENTS
WANT CLEARER
DAYS AHEAD^1*

PLEASE ANSWER THE QUESTION BELOW TO GET STARTED!

How important is it to you to have a rosacea
treatment that’s safe and efficacious?

Very

Somewhat

Not Important

*Clear (IGA score of 0)=no inflammatory lesions present, no erythema.
Almost clear (score of 1)=very few small papules/pustules, very mild erythema present.

Study Design: An investigator-blinded, multicenter, randomized, parallel-group study comparing safety of SOOLANTRA Cream, 1% once daily with MetroCream^® (metronidazole) Topical Cream, 0.75% twice daily in 962 subjects with moderate to severe papulopustular rosacea (IGA score of 3 or 4) over a 16-week treatment period.²

IMPORTANT SAFETY INFORMATION

Indication: SOOLANTRA^® (ivermectin) Cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. Not for oral, ophthalmic or intravaginal use.
Adverse Events: In clinical trials with SOOLANTRA Cream, the most common adverse reactions (incidence ≤1%) included skin burning sensation and skin irritation.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088.

Galderma Laboratories, L.P.
14501 N. Freeway, Fort Worth, TX 76177
© 2020 Galderma Laboratories, L.P. All Rights Reserved. All trademarks are property of their respective owners.
USMP/SOO/0186/0917(1) 01/20

References:

to the Review of SOOLANTRA® (ivermectin) Cream 1% Outcomes in Rosacea Subjects!

ROSACEA PATIENTS WANT CLEARER DAYS AHEAD1*

IMPORTANT SAFETY INFORMATION

to the Review of SOOLANTRA^® (ivermectin)
Cream 1% Outcomes in Rosacea Subjects!

ROSACEA PATIENTS
WANT CLEARER
DAYS AHEAD^1*